HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer

Thomas Group

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Files suit Dec. 27 against Revlon in the 160th Judicial Court of Dallas County, TX to collect approximately $3 mil. "due for incentives earned from services provided to Revlon," the company says. Irving, TX-based Thomas Group provides management services "designed to improve major corporations' competitive positions and profitability," according to the firm. Thomas Group says its expects Revlon to terminate the contract with the company early

Table

View full table

Topics

Tags:
Consumer
Latest Headlines

AI News: Lauder Expands Microsoft Partnership; Prose Beauty; Supply Chain Software; More

Bausch + Lomb’s Prescription For Consumer Health Sales Growth Includes ‘Benefit’ From Rx Drugs

Haleon Capitalizes On Global Rebound Of Dietary Supplement Sales

Chanelle McCoy, Cannaray First To Pass UK FSA’s CBD Safety Assessment

See All
UsernamePublicRestriction

Register

RS000044

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By